Enhancement of mutagenic activity in Salmonella by contraceptive steroids.
Two oral contraceptive steroids, mestranol and norethynodrel, were evaluated for mutagenicity in the Salmonella histidine reversion assay. The pure forms of the hormones were not mutagenic when tested with either missense (TA1535, TA100) or frameshift (TA98, TA1538, TA1537) strains. In vitro activation of the hormones with liver homogenates from rats induced either with phenobarbital or Aroclor did not influence these results. However, mestranol was capable of enhancing the mutation yield obtained by an ineffective subthreshold dose of 2-acetylaminofluorene. Dimethyl sulfoxide extracts of two contraceptive pills, Ovulen-21 (containing mestranol) or Enovid-E (containing mestranol or norethynodrel), also were nonmutagenic. But again, both these extracts were capable of enhancing the mutation yield induced with an ineffective dosage of 2-acetylaminofluorene and N-nitrosopiperidine. These studies point to the possible promotional effect and subsequent potential hazard to the female consumers who use these hormones as a means of pregnancy control.
D003276:Contraceptives, Oral / Q000633:toxicity*; D003278:Contraceptives, Oral, Hormonal / Q000633:toxicity*; D008656:Mestranol / Q000633:toxicity*; D009152:Mutagenicity Tests; D009153:Mutagens; D009641:Norethynodrel / Q000633:toxicity*; D012486:Salmonella typhimurium / Q000235:genetics
D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D009153:Mutagens; D009641:Norethynodrel; D008656:Mestranol